E. Senkus-Konefka

发表

The effects of tamoxifen on the female genital tract.

J. Jassem, E. Senkus-Konefka, T. Konefka, 2004, Cancer treatment reviews.

Complications of breast-cancer radiotherapy.

J. Jassem, E. Senkus-Konefka, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study

K. Pogoda, A. Krętowski, W. Biernat, 2020, Diagnostics.

The requirements of a specialist breast centre

C. Kuhl, F. Cardoso, Alberto Costa, 2020, Breast.

Radiotherapy for breast cancer in patients undergoing breast reconstruction or augmentation.

J. Jassem, J. Jaśkiewicz, M. Wełnicka-Jaśkiewicz, 2004, Cancer treatment reviews.

Sunitinib in breast cancer: friend or foe.

F. Cardoso, E. Senkus-Konefka, 2009, Breast.

A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)

R. Dziadziuszko, J. Jassem, A. Lewandowska, 2005, British Journal of Cancer.

Paliatywna radioterapia chorych na raka płuca Palliative radiotherapy in lung cancer

J. Jassem, E. Senkus-Konefka, 2004 .

International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy

E. Winer, L. Fallowfield, F. Cardoso, 2009, Journal of the National Cancer Institute.

Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD

M. Robson, Bing-he Xu, N. Tung, 2018 .

OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer.

R. Gelber, A. Tutt, S. Lakhani, 2021 .

Cardiac involvement at presentation of non-small-cell lung cancer.

J. Jassem, K. Jaskiewicz, J. Jendrzejewski, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer (OlympiAD): Efficacy in patients with visceral metastases.

M. Robson, Bing-he Xu, N. Tung, 2018 .

BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.

Å. Borg, J. Jassem, G. Palmieri, 2008, Oncology reports.

Cardiovascular effects of breast cancer radiotherapy.

Jacek Jassem, J. Jassem, Elzbieta Senkus-Konefka, 2007, Cancer treatment reviews.

Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?

W. Biernat, E. Senkus-Konefka, M. Kunc, 2018, Cancer treatment reviews.

Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial.

R. Gelber, J. Baselga, J. Mayordomo, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast Cancer Management for Surgeons

C. Markopoulos, M. Leidenius, L. Wyld, 2018, Springer International Publishing.

Influence of brachytherapy applicators geometry on dose distribution in cervical cancer

J. Jassem, A. Badzio, K. Serkies, 1997, Strahlentherapie und Onkologie.

J. Jassem, A. Badzio, E. Senkus-Konefka, 1997, International journal of radiation oncology, biology, physics.

20 Gy in five fractions versus 8 Gy in one fraction in palliative radiotherapy of bone metastases. A multicenter randomized study

J. Jassem, B. Jereczek-Fossa, A. Badzio, 2003 .

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

L. Fallowfield, M. Castiglione, F. Cardoso, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Preferences and treatment possibilities for patients with breast cancer in Poland - questionnaire analysis

J. Jassem, M. Wełnicka-Jaśkiewicz, M. Sinacki, 2006 .

Parallel-opposed fields versus four fields, and two- versus three-dimensional radiotherapy planning in thin patients with gynecological malignancies.

J. Jassem, P. Szewczyk, A. Badzio, 2008, Neoplasma.

139. Parallel-opposed fields vs. four fields, and two- (2D) vs. three-dimensional (3D) radiotherapy planning in thin patients with gynecological malignancies

J. Jassem, E. Senkus-Konefka, M. Górzyński, 2003 .

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

Andrew H. Beck, Clare C. Yu, M. N. Vidya, 2021, npj Breast Cancer.

Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)†

S. Culine, J. Bellmunt, W. Su, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Intraocular malignant teratoid medulloepithelioma in an adult: clinicopathological case report and review of the literature.

J. Jassem, K. Jaskiewicz, R. Kordek, 2006, Acta ophthalmologica Scandinavica.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.

H. Iwata, F. Cardoso, J. Kim, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Feasibility and activity of two vinflunine (VFL)-based combinations as first-line chemotherapy (CT) in CDDP-unfit patients (pts) with advanced urothelial carcinoma (UC): VFL-gemcitabine (GEM) or VFL-CBDCA in a randomized international phase II trial (JASINT).

S. Culine, M. Santis, J. Bellmunt, 2014 .

Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16–20 March 2004

J. Jassem, E. Senkus-Konefka, 2004, Breast Cancer Research.

The requirements of a specialist Breast Centre.

R. Mansel, F. Cardoso, A. Wilson, 2013, European journal of cancer.

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

M. Kris, A. Horwich, C. Buske, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Alveolar rhabdomyosarcoma of the uterine cervix

M. Dudziak, J. Emerich, E. Senkus-Konefka, 1997, Ginekologia Polska.

Molecular diagnostics of cancers – practical approach

M. Krzakowski, P. Rutkowski, L. Wyrwicz, 2023, Nowotwory. Journal of Oncology.

Exacerbation of diabetes related to exemestane treatment

R. Dziadziuszko, J. Jassem, E. Senkus-Konefka, 2008, Acta oncologica.

[Alveolar rhabdomyosarcoma of the uterine cervix].

E. Senkus-Konefka, T. Konefka, M. Dudziak, 1996, Ginekologia Polska.

Changes in lateral dimensions of irradiated volume and their impact on the accuracy of dose delivery during radiotherapy for head and neck cancer.

J. Jassem, A. Badzio, E. Senkus-Konefka, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The perennial natural history of castration-resistant prostate cancer in the patient treated with docetaxel, cabazitaxel and abiraterone acetate

E. Senkus-Konefka, A. Wrona, 2014 .

First-line randomized phase II study of gemcitabine/cisplatin plus apatorsen or placebo in patients with advanced bladder cancer: The International Borealis-1 trial.

C. Sternberg, J. Bellmunt, D. Petrylak, 2015 .